Pfizer and AstraZeneca have announced significant investments in France, totaling around $1 billion, just before the start of the ‘Choose France’ business event.

Pfizer plans to invest $538.5 million in research and development, while AstraZeneca will invest $388 million for its Dunkirk location.

The investments come just before President Macron’s yearly ‘Choose France’ campaign begins.